Roche said its giredestrant drug reduced the risk of disease recurrence or death from breast cancer, suggesting potential for the medication to become standard-of-care when the disease is in the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Roche led a $254 million ...

Roche Holdings AG received CE mark approval for its Elecsys Dengue Ag test, a fully automated, high-throughput immunoassay to help diagnose acute dengue virus infections. With cases of dengue on the ...

This week, the Broad Institute gene-sequencing lab said it read infants’ DNA genomes in less than four hours, cutting an hour off the previous Guinness World Record. The point for investors is that ...

Switzerland-based Roche this week said it has received U.S. regulatory clearance for an Alzheimer’s blood test. This test is used in primary care offices for a patient’s initial assessment of ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...

Oct 13 (Reuters) - Roche Diagnostics (ROG.S), opens new tab said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's (LLY.N), opens new tab blood test as an aid in the ...

The FDA approved a blood test developed by Roche and Eli Lilly to aid in the initial assessment for Alzheimer's disease. The test, called Elecsys pTau181, is intended for patients 55 and older ...

Rules out Alzheimer's pathology in early stages to enhance diagnostic pathway efficiency Provides new opportunity to broaden access and improve referral quality Features as part of Roche's growing ...

(Reuters) -Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an aid in the initial assessment for Alzheimer's disease. This comes ...